Concepedia

46 Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES)

Stephanos J. Hadziyannis, N. Tassopoulos, T.T. Chang, Jenny Heathcote, G. Kitis, M. Rizzetto, Patrick Marcellin, Seng Gee Lim, S.S. Chen, Sarah Arterburn,

Journal of Hepatology · 2004 · 36 citations · 0 references

DOI

Concepts